Your browser doesn't support javascript.
loading
An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus.
Schulte-Wrede, Ursula; Sörensen, Till; Grün, Joachim R; Häupl, Thomas; Hirseland, Heike; Steinbrich-Zöllner, Marta; Wu, Peihua; Radbruch, Andreas; Poddubnyy, Denis; Sieper, Joachim; Syrbe, Uta; Grützkau, Andreas.
Afiliación
  • Schulte-Wrede U; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Immune Monitoring Core Facility, Charitéplatz 1, 10117, Berlin, Germany.
  • Sörensen T; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Grün JR; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Immune Monitoring Core Facility, Charitéplatz 1, 10117, Berlin, Germany.
  • Häupl T; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Bioinformatics Group, Berlin, Germany.
  • Hirseland H; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Steinbrich-Zöllner M; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Immune Monitoring Core Facility, Charitéplatz 1, 10117, Berlin, Germany.
  • Wu P; Department of Gastroenterology, Infectiology and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Radbruch A; Department of Gastroenterology, Infectiology and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Poddubnyy D; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Immune Monitoring Core Facility, Charitéplatz 1, 10117, Berlin, Germany.
  • Sieper J; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Cell Biology Group, Berlin, Germany.
  • Syrbe U; Department of Gastroenterology, Infectiology and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Grützkau A; German Rheumatism Research Center Berlin (DRFZ), an Institute of the Leibniz-Association, Epidemiology Unit, Berlin, Germany.
Arthritis Res Ther ; 20(1): 191, 2018 08 29.
Article en En | MEDLINE | ID: mdl-30157966
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espondilitis Anquilosante / Leucocitos Mononucleares / Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Res Ther Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espondilitis Anquilosante / Leucocitos Mononucleares / Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Res Ther Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania